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The revival of the concept of coronary spasm has stim-
ulated research into coronary artery disease. Observa-
tions in patients with variant angina have substantially
contributed to the appreciation of painless myocardial
ischemia. However, the presence or absence of pain dur-
ing ischemic episodes is not related to the cause of isch-
emia, because painless ischemia can be observed in var-
iant angina (caused by spasm), in effort-induced angina
(caused by increased myocardial demand) and in myo-
cardial infarction (caused by thrombosis).
Continuous monitoring initially of patients with var-
iant angina and subsequently of patients with unstable
and stable angina proved that often painful and painless
ischemic episodes are caused by a transient impairment
of regional coronary blood flow rather than by an ex-
cessive increase of myocardial demand. The transient
impairment of coronary flow appears to be caused by
I amgreatly honoredby the privilegeto give the 1986Bishop
Lecture following such a formidable list of distinguished
predecessors. I am proud of having been assigned this topic
and I will do my best to cover it without bias, separating
facts from extrapolations, very much in the spirit of the late
Louis Bishop.
About 10 years ago, the word spasm used to elicit a
certain smile and I remember being accused now and then
of havinga leaning towardspasm. Then it becamea . 'proven
hypothesis" (I). Now in the 1980sthe pendulumis swinging
too far in the opposite direction and the term spasm is often
used too liberally to describe any form of constriction of
epicardial coronary artery. This generalization is not justi-
fied and I will try to prove it.
In my opinion the major effect of the revival of the
concept of coronary spasm (2) was the stimulus to begin to
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dynamic stenosis of epicardial coronary arteries. This
most often occurs at the site of atherosclerotic plaques
encroaching on the lumen to a variable extent.
Dynamic stenosis can be caused by I) "physiologic"
increase of coronary tone, as in stable angina, 2) spasm,
as in variant angina, and 3) thrombosis, usually in com-
binationwith "physiologic" changesin toneor withspasm,
or both, as in unstable angina. The mechanismsof spasm,
as typically observed in variant angina, are different
from those of "physiologic" increase of tone; they ap-
pear to be related to a local alteration that makes a
segment of coronary artery hyperreactive to a variety
of constrictor stimuli causing only minor degrees of con-
striction in other coronary arteries. The nature of this
abnormality, which may remain stable for months and
years, is yet unknown.
(J Am Coli Cardiol /987;9:249-62)
look at coronary artery disease as a much more varied and
dynamic process than the static and rather stale picture we
were presented with in medical school. The diagram from
my 1983 article in Lancet (3) summarizes fairly well our
views on the varied causes and on the possible clinical
manifestations of myocardial ischemia (Fig. I). In the first
part of my presentation I shall concentrate on the lower part
of the diagram of Figure I dealing with the clinical mani-
festations of acute myocardial ischemia.
Painless Myocardial Ischemia
It appears now fairly well established that acute transient
myocardial ischemia can manifest clinically with angina or
only with signs of acute left ventricular failure or arrhyth-
mias or remain totally silent.
Documentation of Painless Myocardial Ischemia
Variant angina. The study of variant angina (4) played
an important role in our appreciation of painless ischemia.
ln variant angina silent myocardial ischemia was first de-
scribed by Guazzi and coworkers (5,6) in Milan in their
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Figure I. Possible pathogenetic mecha-
nisms and clinical manifestations of myo-
cardial ischemia. Dynamic stenosis is often
caused by vasoconstriction or intravascular
plugging by blood constituents, or both, and
can involve relatively normal as well as se-
verely atherosclerotic segments. These
mechanisms cause ischemia byreducing flow
or by transiently impairing itsappropriate in-
crease. Extracoronary causes are typically
represented bysevere aortic stenosis. Changes
in the small vessels or the myocardium, or
both, are typically represented by syndrome
X. Pain is the most commonly recognized
symptom because it brings thepatient to seek
medical attention. The mechanisms that
produce pain in some ischemic attacks but
not in others are unknown. (Reprinted with
permission from Maseri A 131.)
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Figure 2. Low speed playback of a continuous recording in the
coronary care unit of lead V1 of the electrocardiogram (EKG) and
left (LV) and right (RV) ventricular pressure tracings during two
ischemic episodes not accompanied by pain observed in a patient
with variant angina. Reduction in left ventricular contractility (dP/dO
clearly precedes the onset of ST segment elevation. Another ep-
isode characterized bySTsegment depression andpositive T waves
can be noted on the right side, also preceded and accompanied by
a drop of dP/dt. (Reprinted with permission from Maseri A et al.
171.)
articles of 1970 and 1971 in the BritishHeartJournal, which
I consider to be milestones. In the early 1970s, during our
studies based on hemodynamic monitoring in the coronary
care unit, we demonstrated that totally silent ST elevation
was associated with severe impairment of left ventricular
function. A typical recording taken in 1975 (7) illustrates
the sequence of events during two spontaneous ischemic
episodes (Fig. 2). It is readily apparent that an obvious
impairment of relaxation and constrictor peak left ventric-
ular maximal rate of rise in pressure (dP/dt) and an increase
of all diastolic pressures clearly precede the onset of ST
segment changes. This sequence is remarkably similar to
that observed in dogs after sudden coronary occlusion (8),
and now it can be seen reproduced in humans during coro-
nary balloon angioplasty.
In these hemodynamic studies we confirmed and ex-
panded the observations by Guazzi et al. (5,6) that pain
usually appears only minutes after the onset of ST elevation.
Subsequently, we documented (9) that silent anterior ST
elevation lasting 8 minutes was associated with a transient
massive anterior wall thallium-20l defect (Fig. 3). During
those years we also observed (10, II) that about 70% of
more than 7,000 episodes of ST elevation recorded in the
coronary care unit were painless and that ventricular tachy-
cardia during these episodes was nearly as common in pro-
longed episodes of silent ischemia as in painful ischemia
with ST elevation. In a double crossover trial (12), our group
demonstrated that verapamil reduced the number of painful
and painless ischemic episodes by the same amount (that
is, by about 80%). In another similar study (13), we showed
similar results with intravenous isosorbide dinitrate (Fig. 4).
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Figure 3. Thallium scintigraphy in the
left anterior oblique view during a
painless episode of ST segment ele-
vation lasting 8 minutes (left) showing
a massive anteroseptal defect not vis-
ible in the redistribution image (right).
(Reprinted with permission from Mas-
eri A et al. [91.)
Stable angina. However, silent ischemic ST segment
shifts are not a feature solely of variant angina. A high
frequency of episodes of asymptomatic ST depression dur-
ing Holter monitoring in patients with stable angina had
been previously reported (/4, 15). We also made similar
observations in patients with chronic stable angina. In a
study based on ambulatory electrocardiographic monitoring
for several days of 30 patients with chronic stable angina
(16), our group observed that of 877 episodesof ST segment
depression of I to 2 mm, 83% were painless: of 624episodes
of depression of 2 to 3 mm, 71% were painless: and of 381
episodes of depression of 3 rnm or more. 63% were painless.
In the same study we showed that asymptomatic episodes
Figure 4. A. The total number of episodes in 12 patients with
vasospastic angina in each 48 hour period of the trial. C == run-
in period: AI . A ~ == verapamil periods: B,. B~ == placebo periods.
Control and placebo periods show similar number and type of
ischemic episodes. whereas during treatment with verapamil there
is a conspicuous reduction in frequency of all types of episodes.
both painful and painless. (Reprinted with permission from Parodi
o et al. 1121 .) B, Pooled results in 12 patients with vasospastic
angina. The reduction in the number of the ischemic episodes
during treatment with intravenous isosorbidc dinitrate (ISDN) is
similar both for episodes with ST elevation (ST t ) and for those
with ST depression (ST Ll, either with or without pain. (Reprinted
with permission from Distante A et al. [ 13 1.)
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of ST depression were associated with severe regional de-
fects of rubidium-82 uptake in positron tomographic scans.
Therefore, we decided to investigate the effects of therapy
on painless ischemic ST segment depression in stable an-
gina. Thus, we documented (17) that successful bypass sur-
gery abolished both painful and painless episodes during
Holtermonitoringin 25 patients. Inanotherstudy (18) which
was single blind. double crossover, and placebo-controlled,
we found that atenolol reducedpainfuland painlessepisodes
by 69 and 61 %. respectively. in 10 patients during Holter
monitoring. The results of these two studies indicate that
the effects of successful therapy on painful and painless
episodes are similar to those we had previously observed in
variant angina. although variant angina was treated with
nitrates and calcium antagonists and chronic stable angina
with bypass surgery and beta-receptor blockers.
Therefore. on the basis of all these lines of evidence. we
became convinced that a totally silent transient ischemic ST
segment shift in patients with ischemic heart disease does
indicate severe ischemia and we turned our attention to the
identification of possible differences between episodes of
painful and painless ischemia.
Mechanism of Cardiac Ischemic Pain
Duration and severity of ischemia. In a study per-
formed in patients with variant or rest angina (19). we ob-
served that: I) episodes shorter than 3 minutes were always
painless; 2) episodes associated with an increase of left
ventricular diastolic pressure of less than 7 mm Hg were
also alwayspainless;and 3) longerand moresevereepisodes
could be either painful or painless. Thus. longer duration
and greater severity of ischemia appear to be necessary but
not sufficient conditions to explain the presence of pain.
Role of acute ventricular dilation. Finally. we set out
to investigate whether a different magnitude or rate of ven-
tricular dilation could account for the presence or absence
of pain. In a recent study (20). we continuously monitored
left ventricular volume during episodes of spontaneous or
ergonovine-induced ischemia with and without pain. We
used a single. nonimaging precordial nuclear probe which
detects beat by beat changes in left ventricular volume(after
labeling of the blood pool by technetium-99m pyrophos-
phates) as long as the geometry between the probe and the
ventricle is constant (21). The results of this study show
that the increase of left ventricular end-systolic and end-
diastolic volumes is large during ischemic episodes. either
spontaneous or induced by ergonovine. and both painful or
painless. so that it is impossible to predict the presence or
absence of pain from either the magnitude or the rate of
ventricular dilation.
Activation of painful stimuli during ischemia. These
findings should not be totally surprising if we consider that
more than 20% of myocardial infarctions appear to be un-
accompanied by symptoms recognizable by the patient or
by the observing physician (22). In a recent review of the
subject(23) wearrivedat the following conclusions: I) Short
episodes may be painless because the stimulus is inadequate
or because pain usually appears quite late after the onset of
ischemia. or both. 2) However. severe. prolonged ischemia
(causing massivethalliumperfusion defects, a large increase
of left ventricular end-diastolicpressure and volume, or even
infarction) should represent an adequate painful stimulus.
3) Hence. central transmission or perception. or both. of
potentially painful stimuli is likely to playa major role in
determining the presence or absence of cardiac pain. par-
ticularly in patients who have both painful and painless
episodes of apparently similar severity. (Subsequently. we
occasionallyobservedthat in some patientsthe onset of pain
may precede the onset of detectable ST segment changes.
The reasonsfor this differenceremainthus far unexplained.)
In a series of studies on experimental myocardial isch-
emia Malliani and coworkers (24.25) postulated a partially
restrictedactivation of potentially painfulstimuli. However.
it seems difficult to extrapolate this hypothesis to patients
having apparently similar electrocardiographic severity and
spatial distribution of ischemia during painful and painless
episodes.
An important role of the perception ofpain is supported
by two recent studies . the first by Droste and Roskamm
(26), in patients with totally painless ischemia, and the
second from our institution (27) in patients with predomi-
nantly painless ischemia (more than 95% painless episodes
during Holter monitoring) . Both studies indicate that pa-
tients with painless ischemia have on average a reduced
perception of painful stimuli. However. both studies show
overlap in sensitivity and tolerance to painful stimuli be-
tween some patients with painful and some with painless
ischemia (Fig. 5). Thus. a generalized reduction of the sen-
sitivity to painful stimulation cannot explain all cases of
painless myocardial ischemia. Plasma concentrations of met-
enkephalin and beta-endorphin levels at rest or during pain-
ful stimulation also fail to accountfor these differences(27).
Spectrum of Patients
Some patients may have only painless ischemic episodes
and. therefore, are totally asymptomatic and come to med-
ical attention by chance. They should not be confused with
patients who. although having coronary atherosclerotic ob-
structions. do not have any episodes of ischemia either I)
because the obstructions are not critical or are compensated
by collateral vessels. or 2) because they have no tendency
to develop transient impairment of coronary flow . A mi-
nority of patients have only painful ischemic episodes. The
large majority of patients have both painless and painful
episodes in variable proportion. The proportion of painful
and painless episodes can vary greatly even in the same
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patient, depending not only on the duration of the episodes
but also on a variable transmission or perception of painful
stimuli. Usually, but not always, the patients with frequent
painful ischemic episodes also have frequent painless epi-
sodes; conversely, those with rare painful episodes also have
rare painless episodes. The prevalence of individuals with
silent ischemic-like ST segment changes in the population
appears to be low when the criteria for positivity are strict
(15).
Practical Questions
Two important questions remain to be answered:
I . Does the pathogenetic mechanism of ischemia con-
tribute in any way to determining the presence or absence
of pain? There is no evidence whatsoever to suggest that
the mechanisms of ischemia can influence the presence or
absence of pain. Painless ischemia can be caused by throm-
bosis as in acute myocardial infarction, by spasm as in
variant angina and by excessive increase of demand as in
chronic stable angina.
2. What is the prognostic significance of painless isch-
emia ? It appears reasonable to assume that, for a comparable
severity and duration of ischemia. the prognostic signifi-
cance of painless episodes should be similar to that of painful
episodes because it is actually ischemia that causes both
necrosis and arrhythmias. The available information seems
to support this assumption (22,28- 30). Hence, prognosis
depends on the causes of ischemia and on the general setting
in which it occurs. The presence of pain has potentially
useful and potentially dangerous effects: I) On the one hand.
pain alerts patients to stop activities and to seek medical
attention; on the other, it causes anxiety, increases sym-
pathetic tone and heart work and may favor the onset of
arrhythmias. 2) Conversely, in the absence of pain, patients
are not alerted to stop activities and to seek medical atten-
tion.
Therefore. if I am asked today how I deal with silent
ischemia in my clinical practice. I would say that I do not
consider it reasonable to go out looking for it, except in
individuals suspected to be at very high risk of coronary
artery disease. However. when I come across it by chance,
I am inclined to manage patients with unequivocally doc-
umented silent ischemia in the same way as those with
painful ischemia.
Varied Causes of Acute Myocardial Ischemia
In addition to epicardial coronary artery involvement,
transient acute myocardial ischemia can be brought about
by a variety of other causes: extracoronary causes (such as
aortic stenosis) and small coronary vessel disease. I believe
that the latter disease does exist; it seems to be benign, but
we do not know enough about it. The extent of our knowl-
edge about small vessel coronary disease is concisely sum-
marized by the term proposed by some authors: syndrome
X (31.32). Therefore I will concentrate on the two causes
of ischemia that by far appear to be the most frequent and
of greatest prognostic importance: excessive increase of
myocardial demand in the presence of fixed stenosis, or
sudden impairment of coronary blood flow caused by tran-
sient impairment of flow through epicardial coronary arter-
ies.
Passive Changes in Caliber of Epicardial
Coronary Arteries
Passive changes in caliber of epicardial coronary arteries
can occur (33) and have been demonstrated in elegant ex-
periments in animals (34-36). However , in these studies
the production of the critical stenosis by a ligature magnifies
passive changes, as shown by a study in our laboratory (37)
(Fig. 6). From a pathogenetic point of view the role of
passive -changes should be important only when they are
secondary to changes in prestenotic distending pressure (aor-
tic). In fact, reduction in poststenotic pressure (resulting
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Figure 6. Influence of type of stenosis on coronary flow in re-
sponse to decreasingoutflow pressure in five dog carotid arteries.
A, Intravascular balloon stenosis: when outflow pressure (P2) is
lowered and thereby pressure difference across the stenosis (IlP)
is increased. flow increases as well. D, Circumferential snare ste-
nosis: when P2 is lowered. flow decreases. A marked decrease
occursonly when P2 is lowerthan 30 mm Hg. Each lineof symbols
in A and D represents the same vessel with internal stenosis in A
and external stenosis in D. (Reprinted with permission from von
Arnim T et al. [37].)
from arteriolar vasodilation) should not affect flow because
compliant stenoses should act as Starling resistors (38).
Conversely, a reduction in aortic pressure can also cause
ischemia independently from passive reduction in the coro-
nary lumen when coronary flow reserve is minimal. so that
coronary flow depends on perfusion pressure. I will limit
my discussion to the causes of active dynamic stenoses of
epicardial coronary arteries which, together with increased
myocardial oxygen demand, often coexist in variable com-
bination or concur to cause ischemia in the same patient.
Varied Causes of Active Dynamic Stenosis
The possible causes of active dynamic stenosis are the
following: I) "Physiologic" response of coronary smooth
muscle to constrictor stimuli in the presence of a subintimal
plaque in a pliable segment of artery; 2) hyperresponse to
ordinary constrictor stimuli or abnormal stimuli resulting in
total or subtotal occlusion of a segment of coronary artery;
3) intravascular plugging by platelets and thrombus; 4) com-
bination of causes 3 + I or 3 + 2 or 2 + 3.
Intravascular plugging by platelet aggregates and throm-
bosis probably plays a major role in severe unstable angina
resistant to medical therapy (39-41), most likely in com-
bination with increased vasomotor tone or with spasm. Spasm
is typically recognized in variant angina (4), which is a rare
syndrome. A "physiologic" increase of coronary smooth
muscle tone is likely to play the major role in determining
~~
"'·"'·':'10 10 0~ P,
I I I I I I mmHg
60 70 80 9O}OO 60 70 80 90 }OO f).p
the variability of exercise tolerance and episodes of spon-
taneous ischemia in patients with chronic stable angina.
"Physiologic" Coronary Vasoconstriction
Control of normal coronary tone. A number of features
distinguish spasm from "physiologic." ("Physiologic"
coronary constriction is in quotes to allow contemplation of
the possibility that vasomotor changes of this magnitude
could be caused by pathologic mechanisms.) coronary con-
striction. "Physiologic" coronary constriction represents a
normal response. because vasoconstrictor stimuli produce a
rather predictable and uniform but small reduction of caliber
in all epicardial coronary arteries. The magnitude of the
constriction depends on vascular basal tone, reactivity and
compliance. The mechanisms that control normal coronary
tone are poorly understood. Complex neuromodulation by
corelease of transmitters (42) appears to be integrated with
endothelial control (43). Neuropeptides are probably also
involved in this regulatory process. A recent study by our
group (44) showed that a calcitonin gene-related peptide,
naturally present in cardiac nerves, is a very powerful dilator
of epicardial human coronary arteries in vivo. The effect of
"physiologic" smooth muscle constriction, which usually
reduces the normal diameter by 10 to 20%. may be mag-
nified by the presence of a subintimal plaque when the
arterial wall is pliable (45).
Physiologic constriction versus spasm. A major dis-
tinctive feature between physiologic coronary constriction
and spasm is demonstrated by a classic study (46) on un-
selected patients with chronic stable angina. During hand-
grip the caliber of both normal and stenotic segments is re-
duced on average by about 10% and trans tenotic resistance
increased by about 40%. Conversely, after nitroglycerin
both normal and stenotic segments dilate about 20% and
transtenotic resistance decreases by about 20%. Thus, on
the average, transtenotic resistance appears to vary by as
milch as 60%; obviously in some patients it may vary more,
in others less. This behavior, observed in a group of un-
selected patients, is indicative of a common type of re-
sponse, hence "physiologic," quite at variance with the
rarity of coronary artery spasm at least of the kind seen in
variant angina. Subsequent studies (47) indicate that eccen-
tric but not concentric lesions can vary their caliber because
they are more pliable. Postmortem studies (48) indicate that
about 75% of stenoses are eccentric and pliable.
Heart rate and blood pressure during ischemic epi-
sodes. Changes of transtenotic resistance of the magnitude
calculated by Brown et al. (46) can well account for im-
portant variations of the ischemic threshold. They may well
explain the observations made during ambulatory monitor-
ing in patients with chronic stable angina. A number of
other studies (14-16,49) indicate that most ischemic epi-
sodes recorded during ordinary daily life are not preceded
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Figure8. Variable coronary flowreserve . Residual coronary flow
reserve may have an upper limit that is indeed fixed, but can
decrease transiently because of the presence of mechanisms that
transiently interfere with coronary blood flow . Thus, the residual
coronary flow reserve can vary throughout the day. Under these
conditions, if the patient exercises beyond the maximal residual
coronary flow reserve he will always develop ischemia (8) . How-
ever. he mayalsodevelop ischemiaonotheroccasionsaftersmaller
degreesofexercise. when residual coronary flowreserve is reduced
by these functional factors (e) . Occasionally, coronary flow re-
serve candecreaseso that rest fl owis impaired and ischemia occurs
at rest (D). At other times of the day, this patient can exercise
below the level of his maximal residual coronary flow reserve
without experiencing ischemia (A). (Modified with permission
from Maseri A et al. [52]. )
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by an increase of heart rate. Chierchia et al. (50) confirmed
these findings by beat by beat computer analysis of Holter
ambulatory electrocardiographic tapes showing that on other
occasions large increases in heart rate were not associated
with ST depression. Moreover, our computer analysis of
tapes obtained at Northwick Park Hospital by Chierchia et
al. (51) during ambulatory monitoring of blood pressure.
indicated that the majority of ischemic episodes were not
preceded by an increase in heart rate-blood pressure product
greater than those tolerated at other times of the day without
any signs of ischemia. How can these findings be explained'?
Role of fixed coronary flow reserve. It is apparent that
these observations are rather difficult to reconcile with the
traditional view that the impairment of coronary flowreserve
caused by coronary occlusion is fixed (the result of the
balance between severity of a critical stenosis and devel-
opment of collateral vessels). This traditional concept is
illustrated in the scheme presented in Figure 7: residual
coronary fl ow reserve is reduced moderately so that myo-
cardial perfusion can increase, for example, up to three times
the level at rest but no more. This fixed impairment of
coronary flow allows the patient to increase his total body
oxygen consumption about 10 times (\0 multiples of basal
metabolic oxygen consumption [METs]) without developing
ischemia, but ischemia will develop for efforts greater than
10 METs. Obviously this scheme is an approximation be-
cause a variable cardiac adaptation to exercise may allow
Figure 7. Fixed coronary flow reserve. Schematic illustration of
the relation between physical activity (during the 24 hours) ex-
pressed in multiples of basal metabolic oxygen consumption (METs)
and increase incoronary flow reserve . When myocardial metabolic
demand increases, coronary flow can normally increase at least up
to fourto six times the value at rest to match the increased demand
of flow by the myocardium so that no ischemia occurs. The pres-
ence of fi xed coronary artery obstructions, not adequately com-
pensated by collateral vessels. may reduce coronary flow reserve .
In this schematic diagram it is reduced to three times the values
at rest. The patient can exercise up to about 10 METs (dashed
line) without having ischemia (A); however. if he exercisesabove
about 10 METs he will consistently develop ischemia (B). (Mod-
ified with permission from Maseri A et al. 1521.)
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the patient to perform slightly more or slightly less than 10
METs without developing ischemia (up to about 12or down
to only 8) for the same degree of limitation of coronary flow
reserve. In any case, a fixed reduction of coronary flow
reserve can explain only rather moderate variations of the
ischemic threshold (± I or 2 METs).
Variability of residual coronary flow reserve in stable
angina. The very wide variability of the ischemic threshold
often observed during ambulatory monitoring in many pa-
tients with chronic stable angina appears more compatible
with the modification of the traditional scheme of fixed
residual coronary flow reserve illustrated in Figure 8. In this
scheme residual coronary flow reserve is reduced to three
times the level at rest but it is not fixed during the 24 hours
as it is modulated by changes in resistance at the site of the
fl ow-limiting stenoses. Thus, occasionally flow may bedra-
matically reduced to produce ischemia at rest, or coronary
fl ow reserve may be only moderately reduced so that isch-
emia develops only in coincidence with moderate efforts.
well tolerated on other occasions. Also, in this diagram
efforts greater than about 10 METs are never tolerated but
lesser efforts may or may not cause ischemia depending on
the simultaneous behavior of coronary flow reserve. This is
a schematic representation of a kind of mixed angina (52)
in which ischemia can be caused both by transient changes
in transtenotic resistance and by increased demand or by
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their combination. Changes in coronary vasomotor tone at
the site of pliable stenoses are thought to contribute to the
variability of ischemic threshold in patients with chronic
stable angina (53-55) . The causes of mixed angina in pa-
tients in unstable condition are more complex (56).
Changes in vasomotor tone versus spasm. We were
able to document a number of features that suggest that the
changes of vasomotor tone responsible for this wide vari-
ability of residual coronary fl ow reserve in chronic stable
angina are different from spasm. at least in the form that is
most commonly seen in variant angina. Crea et al. (57)
showed that patients with chronic stable angina may have
a positive ergonovine test but never with ST elevation or
coronary occlusion. They also showed (58) that these pa-
tients often have a positive cold pressor test but never a
positive hyperventilation test; Chierchia et al. (59) showed
that such patients have predominantly diurnal ischemic ep-
isodes as opposed to patients with variant angina. More
recent studies (60.61) in patients with total occlusion of a
major branch as the only detectable coronary lesion suggest
that change of resistance at the site of small vessels may
infl uence the ischemic threshold during effort. This possi-
bility is supported by results obtained in dogs (62).
Corollary Artery Spasm
Besides these observations and the rarity of variant an-
gina. a final conclusive indication that spasm. as typically
seen in variant angina, is totally different from the ' ' phys-
iologic" changes in coronary vasomotor tone seen in normal
subjects and in those with chronic stable angina is provided
by the results of a series of studies on the pathogenetic
mechanisms of spasm that we have performed during the
last few years in patients with variant angina. In our review
(63). spasm was defined as: "Inappropriate active constric-
tion of a segment of coronary artery resulting in total or
subtotal occlusion in response to stimuli which cause only
minimal constriction in individuals who do not have the
symptoms of variant angina." It is best recognized in "var-
iant" angina. but it is possible that some other forms of
spasm may play a role in other ischemic coronary syn-
dromes.
Transitional forms of coronary spasm. In our initial
studies we were impressed by transitional forms. between
typical variant angina with ST elevation and spontaneous
angina with ST depression. We have shown (64) that in
variant angina spasm can involve apparently normal vessels
or severely stenotic arteries resulting in ST elevation or
depression with a similar location and morphology whether
occurring spontaneously or induced by ergonovine. In sub-
sequent studies (65.66) based on monitoring of left ven-
tricular pressure and of coronary sinus oxygen saturation by
a fiberoptic catheter in the coronary care unit. we observed
that a reduction of oxygen saturation in the coronary sinus
(Fig. 9) was the first detectable change not only in patients
with variant angina but also in those with rest angina. We
also observed in a series of thallium-201 studies (67.68)
that most cases of rest angina with ST depression were
associated with a regional decrease of thallium uptake sug-
gesting that they were caused by a reduced coronary per-
fusion rather than by increased demand. We observed a
wide variety of clinical presentations with transition forms
between the most typical features of variant angina and those
of rest angina. Finally. we (69) documented possible pro-
gression to infarction in the region supplied by the artery
undergoing spasm. as subsequently found also by others
(70- 72). Therefore, in a report ( I I) based on the observation
of 138 patients. we proposed that variant angina was an
aspect of a continuous spectrum of vasospastic myocardial
ischemia. Similar conclusions were reached by other groups
in large series of patients (73,74) .
Possible mechanisms of spasm in variant angina. Al-
though we have noted and emphasized both the variable
clinical and angiographic feature s of coronary spasm in var-
iant angina and in transitional forms and the sudden reduc-
tion of coronary blood supply as the most frequent cause
of spontaneous myocardial ischemia at rest. we chose to
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Figure9. Lowspeed playback(paper speed 0.3 rnm/s)
of electrocardiogram (ECG). coronary sinus O2 satu-
ration (CS0 2s). left ventricular pressure (LVP) and
maximal rate of rise in pressure (dP/dO during three
successive asymptomaticepisodesrecorded ina patient
over a period of about 15 minutes. At the top are
electrocardiographic patterns (lead V2) in rest condi-
tions (a). at the onset (b) and at the peak (c) of the
ischemic episode. Vertical linescorrespond to the on-
set of the ST-T changes. A sharp drop of CS02s con-
sistently precedes the onset of the electrocardiographic
and hemodynamic changes . The same pattern contin-
ued uninterrupted for a totalof 26episodes. after which
all the variables remained stable without any interven-
tion until the nextepisode which occurred about I hour
later. (Modified with permission from Chicrchia S. ct
al. 1651.)
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investigate the mechanisms of spasm only in patients with
the most typical clinical form of variant angina.
About 10 years ago we proposed (9) the fo llowing work-
ing hypoth esis on the patho genetic mechanisms of spasm in
variant angina: "The usual recurrence of ST segment changes
in the same leads and of spasm in the same artery suggest
the presence of two causes: I) A local factor that makes the
vessel hypersensitive to constrictor stimuli to a variable
extent in different phases of the disease. 2) A series of
triggering mechanisms that cause spasm and may be dif-
ferent in different patients and even in the same patient at
different times."
Aware of the difficulty to identify the local alteration we
initially tried to assess the role of triggering factors by at-
tempting to prevent the development of spasm by a number
of specific drugs, but we had a series of negative results.
We were unable to document any beneficial effect of low
dose aspirin (75), prostacyclin (76) or phentolamine (77)
and we could not prevent the spasm with ketanserin, a
serotonin inhibitor (78). These negative results results arc
consistent with other findings (79-81 ).
Although the reasons for negative results can be multiple.
this series of negative results is also compatible with a
dominant role of a nonspecific local hypersensitivity to a
variety of constrictor stimuli. Indeed some reports (82-84)
indicatethat a varietyof constrictor agents can inducespasm
in patients with variant angina.
Spasm as a localized abnormality . A recently completed
systematic study in our institution (85) appears to support
this possibility rather strongly. Of 40 patients with active
typical variant angina studied during the last 5 years. 2g
were submitted to a series of provocative tests within 3
weeks while in an active phase of the disease. In all, spon-
taneousor inducedspasm was demonstrated at angiography.
The provocative tests included: ergonovine, hyperventila-
tion, exercise testing. cold pressor, handgrip. histamine (15
patients), and vasopressin (Pitressin) (8 patients). All tests
were performed in the noninvasive laboratory during con-
tinuous 12 lead electrocardiographic recording. Several pa-
tients had a positive response to more than one type of
constrictor stimulus known to act on different receptors.
Ergonovine administered in doses of 25, 50, 100. 200 and
300 J.Lg at 5 minute intervals. was, by far. the most powerful
spasmogenic stimulus, producing a positive response in 27
of the 28 patients. Other tests with perhaps the exception
of hyperventilation and histamine, more often produced a
positive response when the response to ergonovine was pos-
itive at a low dose (Table I). (Recently Crea et al. [88]
showed that in patients with variant angina spasm can also
be produced by intravenous dopamine.)
Because ergonovine was by far the most powerful spas-
mogenic stimulus in vivo, contrary to findings in isolated
human coronary arteries (86). we thought it legitimate to
investigate whether this drug acted directly on the coronary
arteries or indirectly by triggering coronary constrictor stim-
uli originating in other parts of the body. Hackett et al. (87)
in our institution resolved this doubt by showing that the
intracoronary injection of ergonovine caused spasm in all
six patients with variant angina tested and in none of the
nine control patients. The dose at which intracoronary er-
gonovine was effective (20.7 J.Lg on the average) corre-
sponded to about 10% of the effective intravenous dose.
The time lag between the intracoronary injection and spasm
was 60 to 180 seconds.
Computerized analysis of the high resolution angiograms
by an automatic edge detection program allowed us to con-
struct dose-response curves. The preliminary results of this
analysis indicate that only spastic segments hyperreact to
ergonovine n~9,90) but not the proximal segments of the
same branches or the other branches, which behave like the
Table I. Result s of a Ser ies of Pro vocative Tests in 28 Patient s With Active Variant Angina
Patient s with a positi ve response to ergo nov ine
Patients with a positive response to the other
provocative tests
Hyperv ent ilation
Histamin e
Exercise
Cold pressor
Handgri p
Vaso pressi n (Pitress in)
Ergo novine iv Dose (iLgl
roo 200 3tK)
IX 6 3
X of 18 2 of 6 2 of J
4 of 'J I of 2 2 of 3
4 of IX 4 of 6
3 of 18
2 of IS'
I of 5 I of 3
Data are take n with perm ission from Kask i JC et al. HI5); those for Pitressin are unpubl ished . Eighteen
patient s had a pos itive response at an ergonovi ne dose of 100 iLg. 6 at a dose of 200 iLg and 3 at a dose of
300 iLg. Below each column is indica ted the numb er of patients with a positive response til the other provocative
tests. One of the 28 patien ts had a negative response to ergonovine and to all other tests . iv = intraven ous .
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arteries of control patients and show only 10 to 20% re-
duction of diameter (a physiologic response) similar to that
observed in control subjects after intravenous injection of
ergonovine. The effective dose that causes 50% of the max-
imum constriction (EDso) of the spastic segment and of the
other branches was not signifi cantly different. Thus. total
occlusion of a coronary artery segment appears to result
from a local hyperresponse to the same dose of ergonovine
that causes only physiologic constriction in other branches
or in other patients. This behavior is quite different from
that in hypercholesterolemic animal models in which the
dose response to constrictor agents is markedly shifted to
the left (9 1).
Theref ore. in this interesting human model of disease
that is variant angina in its most typical form: I) Spasm
can be caused by a variety of constrictor stimuli acting on
different receptors. This is compatible with a local alteration
of a segment of the arterial wall that makes it hyperreactive
to a variety of constrictor stimuli. 2) The documented per-
sistence of spasm (in the absence of therapy) for 6 to 48
months in 10 of the 28 patients suggests that the local seg-
mental alteration is often chronic and stable.
Nature of the local alteration in spastic segments. The
alteration responsible for the local arterial hyperreactivity
to constrictor stimuli must be quite uncommon because the
syndrome is rare. In our studies we could not detect dif-
ferences in reactivity when the spasm occurred at the site
of an obstructive plaque or in an angiographically normal
artery. Therefore the presence of a subintimal plaque en-
croaching critically on the lumen (4) is clearly not a nec-
essary element for the occurrence of spasm in variant angina.
as already suggested by Freedman et a!. (92). Indeed. al-
though the geometric effect of a plaque can modulate trans-
stenotic fl ow resistance during generalized "physiologic"
changes of coronary smooth muscle tone (44), it does not
lead to coronary occlusion during intravenous ergonovine
challenge in patients with stable angina (93) even when
stenoses are multiple and very severe (45).
Having established that in typical variant angina coronary
occlusion is not the result of a diffuse coronary constriction
that only occludes the segment site of a critical plaque (4.44).
the local chronic abnormality responsible for the hyper-
reactivity may be in the smooth muscle. in the cellular
components of the adventitia. in the intima or in the peri-
vascular neural plexus.
Postmortem studies of segments ofa coronary artery site
ofspasm are few . One report (94) describes a fibromuscular
dysplasia that might be primary or secondary, but the ma-
jority of reports fail to reveal special features of the wall
which in some studies (95-98). had a variable degree of
atheromatosis and in others was histologically normal
(99.100). However, it is difficult to draw firm conclusions
from postmortem studies not performed with the specific
aim of identifying the possible presence of unknown local
alterations. An increase in periarterial mast cells was re-
ported in a patient with variant angina (101); however, the
significance of this find ing is diffi cult to assess because mast
cells are present in variable amounts in coronary arteries of
patients dying from ischemic heart disease (102).
The recent surge of interest in the role of endothelium
in controlling vascular smooth muscle tone (/ 03 ) raises the
possibility that a local endothelial alteration may be re-
Figure 10. Left coronary angiogram in a patient with a history
of atypical chest pain (no radiation. duration 20 to 40 minutes.
either spontaneous or broughton by emotion or effort) not repro-
duced by exercise stress test or ergonovine test (ERGO). which
also failed to produce ischemic electrocardiographic changes. The
change in arterial diameter between theergonovine and postnitro-
glycerin (GTN) angiograms isgeneralized and inseveral segments
exceeds 100% (which implies a 400% change in lumen) . It is
conceivable that a similar constriction could produce ischemia
during increased myocard ial demand.
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sponsible for the hyperactivity of coronary artery segments .
However, this possibility must be considered rather cau-
tiously . The role of the endothelium-derived relaxing factor
in coronary arteries in humans appears different from that
observed in animals (104 ,105). Indeed, in human coronary
artery rings with intact endothelium, acetylcholine consist -
ently causes constriction (86). Also , in patient s acetylcho-
line has a constrictor effect in most coronary segments
(106 ,107). Hence , this type of reaction is obviously far too
common to be considered among the causes of spasm in
variant angina, although it could be a mechanism of " phys-
iologic" changes of vasomotor tone . Ulceration of plaques
and a particular phase of plaque development (108) also
appear unlikely causes of the local susceptibility to spasm
because they seem to be too frequent and the hyperreactivity
can persist unchanged for months and years.
Finally, the observation of spasm in transplanted hearts
(109) suggests that spasm may occur independently from
the control of the central autonomic nervous system. How-
ever, alterations of the local periarterial nervous plexus can-
not be ruled out because the occasional cyclic pattern of
spasm recurring at regular interval s of a few minutes , al-
ready observed by Prinzmetal et al . (4) and of which we
have presented examples (65,69) (Fig. 9), suggests a pos-
sible alteration of the local feedback mechanism that con-
trols local smooth muscle tone.
Intriguing questions. I) Occasionally in patients with
or without a typical history of variant angina an intense
diffuse constriction of all coronary branches can be seen
during the ergonovine test and even spontaneously (64, 110).
This may be associated with ST elevation or ST depression
with chest pain or without electrocardiographic changes or
even without any apparent sign or symptom of ischemia
(Fig. 10). Is the mechanism responsible for these nonseg-
mental forms of spasm different?
2) Spasm has been postulated in allergic reactions
(111,112) ; is it possible that stimuli exist that are so pow-
erful as to cause total coronary occlusion in the absence of
local hyperreactivity to constrictor stimuli?
3) Spasm has been reported after chronic nitrate expo-
sure (113) ; was it induced by the exposure or was it evi-
denced during withdrawal in patients who happened to have
vasospasm ? Spasm refractory to nitrates has been reported
(114, 115); is it possible that under some circumstances spas-
tic segments or some forms of spasm may not be responsive
to nitrates or other vasodilator drugs , as is the case of cath-
eter-induced spasm in brachial arterie s and veins? If this is
the case, is this lack of response caused by the persistence
of the stimulus or by some particular form of contraction
such as the formation of " latch" bridges ( I I6)? Two studies
(117 ,I 18) documented the persistence of spasm at post-
mortem in four patients with variant angina who died during
an attack; can these findings be explained by some form of
rigor of smooth muscle (119)?
General Implications
Quiescent phase of coronary artery disease. The re-
vival of the concept of coronary spasm has stimulated re-
search and thought that is expanding our understanding of
coronary disease . As a first appro ximation we can assume
that in the absence of mechani sms causing transient im-
pairment of regional coronary flow, even in the presence of
atherosclerotic obstructions , coronary disease is in a quies-
cent phase (120). When coronary disease is in a quiescent
phase, the only possible cause of ischemia is an excessive
increase of myocardial demand beyond the ischemic thresh-
old set by the balance between obstructions and collaterals .
Active phase of coronary artery disease. Dynamic
coronary stenoses are responsible for active phases of coro-
nary disease in which ischemia also occurs independently
of excessive increase of myocardial demand. During active
phases the disease may be stable, with the picture of chronic
stable angina and variable effort tolerance , or may be un-
stable with organic stenoses progressing rapidly or suddenl y
because of thrombotic deposition (39) .
Local coronary artery hypersensitivity early in coro-
nary thrombosis. The concept of a local vascular abnor-
mality that can cause coronary segments to become occluded
in response to constrictor stimuli that produce only a modest
constriction in other branches might be extrapolated. If we
reexamine now the varied causes of active dynamic stenoses
we could entertain the poss ibility that mural or intraintimal
white thrombus formation may be associated with only mod-
erate constriction or with occlusive spasm depending on the
local react ivity of the smooth muscle. If this hypothesis is
valid, then a local hyperreactivity of the coronary smooth
muscle might play a role in some cases in the very early
phase of coronary artery occlusion; subsequently, when the
arterial segment is totally occluded a red thrombus is likely
to form, especially in diseased arteries, and can maintain a
total occlusion even when a spasm is relieved. The 20%
incidence of positive ergonovine tests in patients with recent
infarction observed by Bertrand et al. (121) would lend
.support to the hypothesi s that a local coronary artery hy-
perreacti vity is frequent in acute myocardial infarction .
The rarity of acute persistent coronary occlusion in the
life of patients with even severe coronary atherosclerosis
compared with the frequent finding of plaque fissures in
patients dying of noncardiac causes and with the frequenc y
of transient spasm in variant angina suggests either a rare
mechani sm or the simultaneous occurrence at the same site
of more than one pathologic event (122). A combination of
local alterations (plaque fissure, increased susceptibility to
constrictor stimuli or vice versa) together with displacement
of the local thrombotic/thrombolytic equilibrium toward
thrombosis may be required to initiate occlusion and c101
formation unless large plaques become ulcerated or unless
irreversible spasm occurs for mechanisms yet unknown (123).
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Conclusions
In my presentation I have shown how occasional obser-
vations may prompt systematic studies and how the results
of studies can modify our thinking and suggest new hy-
potheses that in tum have to be tested. At this stage the
hypotheses clearly extend beyond the supporting evidence
provided by available data. However, because we see nature
in the light of the questions we ask, we ought to be curious
and keep asking questions with an inquisitive mind. Some
may be the right questions.
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